<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04947735</url>
  </required_header>
  <id_info>
    <org_study_id>CPRO-1802-002</org_study_id>
    <nct_id>NCT04947735</nct_id>
  </id_info>
  <brief_title>CYPRESS Efficacy and Safety Study Extension</brief_title>
  <acronym>CYPRESS</acronym>
  <official_title>Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study Extension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SightGlass Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SightGlass Vision, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label, controlled, multisite, two-arm parallel group clinical trial of&#xD;
      36-month duration to evaluate the continued safety and efficacy of SightGlass Vision&#xD;
      Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Axial length</measure>
    <time_frame>72 months</time_frame>
    <description>Test vs. control axial length change from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spherical equivalent refraction (SER)</measure>
    <time_frame>72 months</time_frame>
    <description>Test vs. control spherical equivalent refraction (SER) change from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axial length</measure>
    <time_frame>42 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SER</measure>
    <time_frame>60 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Juvenile Myopia</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>CYPRESS Extension Test Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single vision, impact resistant spectacle lenses; CYPRESS Test Arm 1 and CYPRESS Test Arm 2 will move into CYPRESS Extension Test Arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CYPRESS Extension Control Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single vision, impact resistant spectacle lenses; CYPRESS Control Arm remains in control lenses as the CYPRESS Extension Control Arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Novel spectacle lens design</intervention_name>
    <description>Use of single vision, impact resistant spectacle lenses may reduce the rate of progression of juvenile myopia</description>
    <arm_group_label>CYPRESS Extension Test Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectacle lenses</intervention_name>
    <description>Single vision, impact resistant spectacle lenses</description>
    <arm_group_label>CYPRESS Extension Control Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Previously a successfully completed participant in the CYPRESS study (NCT03623074) and&#xD;
             having not exited this study for more than 30 days;&#xD;
&#xD;
          -  Agree to wear the assigned spectacles constantly except for sleeping, swimming, or&#xD;
             other activities in which spectacle wear would be dangerous or otherwise not possible&#xD;
             (minimum of 10 hours per day);&#xD;
&#xD;
          -  Willingness to participate in the trial for up to 3 years without contact lens wear;&#xD;
&#xD;
          -  The subject's parent(s) or legal guardian(s) must read, understand and sign the&#xD;
             Statement of Informed Consent and receive a fully executed copy of the form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known allergy to proparacaine, tetracaine, or tropicamide.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joseph Rappon, OD, MS, FAAO</last_name>
    <phone>678-643-9117</phone>
    <email>joe@sightglassvision.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vanessa Tasso, MA, MBA</last_name>
    <phone>949-751-7039</phone>
    <email>vanessa@sightglassvision.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Golden Optometric Group</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Ardaya, OD, MHA</last_name>
      <phone>562-692-1208</phone>
      <email>dca@goldenoptometric.com</email>
    </contact>
    <investigator>
      <last_name>David Ardaya, OD, MHA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sabal Eye Care</name>
      <address>
        <city>Longwood</city>
        <state>Florida</state>
        <zip>32779</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Warren</last_name>
      <phone>407-869-4733</phone>
      <email>sabaleyecare@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Christopher Pearson, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Torrance</last_name>
      <phone>620-235-1737</phone>
      <email>jtorrance@kannarreyecare.com</email>
    </contact>
    <investigator>
      <last_name>Shane Kannarr, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Associates of Northeast Louisiana (DBA Haik Humble Eye Center) Research Dept</name>
      <address>
        <city>West Monroe</city>
        <state>Louisiana</state>
        <zip>71291</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Latha Jois</last_name>
      <phone>800-247-5878</phone>
      <email>ljois@eyenela.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Scogin, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Eyecare PC</name>
      <address>
        <city>Raytown</city>
        <state>Missouri</state>
        <zip>64133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Urias</last_name>
      <phone>816-353-1872</phone>
      <email>tammy@bso-ae.com</email>
    </contact>
    <investigator>
      <last_name>Richard Wilson, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY School of Optometry</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>C Ray</last_name>
      <phone>212-938-4052</phone>
      <email>Clinicresearch@sunyopt.edu</email>
    </contact>
    <investigator>
      <last_name>Xiaoying Zhu, Od, Phd, MS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sacco Eye Group</name>
      <address>
        <city>Vestal</city>
        <state>New York</state>
        <zip>13850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Staci Sacco</last_name>
      <phone>607-798-1987</phone>
      <email>Researchcoordinator@saccoresearch.com</email>
    </contact>
    <investigator>
      <last_name>Andrew Sacco, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dunes Eye Consultants</name>
      <address>
        <city>Dakota Dunes</city>
        <state>South Dakota</state>
        <zip>57049</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea</last_name>
      <email>andrea@duneseye.com</email>
    </contact>
    <contact_backup>
      <last_name>Tracie</last_name>
      <email>tracie@duneseye.com</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Ferguson, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Bridgitte Shen Lee (PI)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridgitte Lee, OD</last_name>
      <phone>713-804-6216</phone>
    </contact>
    <investigator>
      <last_name>Bridgette Lee, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William J Bogus, OD, FAAO</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cris Bogus</last_name>
      <email>crisbogus@msn.com</email>
    </contact>
    <investigator>
      <last_name>William Bogus, OD, FAAO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre for Ocular Research and Education</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyndon Jones, PhD, FCOptom</last_name>
      <phone>+1 519-888-4567</phone>
      <phone_ext>36743</phone_ext>
      <email>jwoods@uwaterloo.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

